EUVIMEDEUVIMED entdecken
Klinische Studie

Safety and Feasibility of Irreversible Electroporation (IRE) in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective Study

Salvatore Paiella, Giovanni Butturini, Isabella Frigerio, Roberto Salvia, Giulia Armatura, Matilde Bacchion, Martina Fontana, Mirko D'Onofrio, Enrico Martone, Claudio Bassi

Digestive Surgery · 2015 · 32 (2) · 90-97

DOI: 10.1159/000375323 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Digestive Surgery, online erschienen am 28.02.2015. Verfasst von Salvatore Paiella und 9 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Pancreatic and General Surgery, The Pancreas Institute, G.B. Rossi Hospital, University of Verona Hospital Trust, Verona, Italy. Hauptthemen laut MEDLINE: Electroporation. Die Arbeit wurde bisher 117-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the safety of the NanoKnife Low Energy Direct Current (LEDC) System (Irreversible Electroporation, IRE) in order to treat patients with unresectable pancreatic adenocarcinoma.

Methods

Prospective, nonrandomized, single-center clinical evaluation of ten patients with a cytohystological diagnosis of unresectable locally advanced pancreatic cancer (LAPC) that was no further responsive to standard treatments. The primary outcome was the rate of procedure-related abdominal complications. The secondary endpoints included the evaluation of the short-term efficacy of IRE through the evaluation of tumor reduction at imaging and biological tumor response as shown by CA 19-9, clinical assessments and patient quality of life.

Results

Ten patients (5 males, 5 females) were enrolled, with a median age of 66 and median tumor size of 30 mm. All patients were treated successfully with a median procedure time of 79.5 min. Two procedure-related complications were described in one patient (10%): a pancreatic abscess with a pancreoduodenal fistula. Three patients had early progression of disease: one patient developed pulmonary metastases 30 days post-IRE and two patients had liver metastases 60 days after the procedure. We registered an overall survival of 7.5 months (range: 2.9-15.9).

Conclusions

IRE is a safe procedure in patients with LAPC and may represent a new technological option in the treatment and multimodality management of this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ElectroporationAdenocarcinomaAgedFeasibility StudiesFemaleFollow-Up StudiesHumansMalePancreatic NeoplasmsPostoperative ComplicationsProspective StudiesQuality of LifeTreatment Outcome

Autor:innen und Institutionen

  • Unit of Pancreatic and General Surgery, The Pancreas Institute, G.B. Rossi Hospital, University of Verona Hospital Trust, Verona, Italy.

Zitieren

APA

Paiella, S., Butturini, G., Frigerio, I., Salvia, R., Armatura, G., Bacchion, M., Fontana, M., D'Onofrio, M., Martone, E., & Bassi, C. (2015). Safety and Feasibility of Irreversible Electroporation (IRE) in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective Study. Digestive Surgery, 32(2), 90-97. https://doi.org/10.1159/000375323

Vancouver

Paiella S, Butturini G, Frigerio I, Salvia R, Armatura G, Bacchion M, et al. Safety and Feasibility of Irreversible Electroporation (IRE) in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective Study. Digestive Surgery. 2015;32(2):90-97. doi:10.1159/000375323

BibTeX
@article{Paiella2015,
  author = {Paiella, Salvatore and Butturini, Giovanni and Frigerio, Isabella and Salvia, Roberto and Armatura, Giulia and Bacchion, Matilde and Fontana, Martina and D'Onofrio, Mirko and Martone, Enrico and Bassi, Claudio},
  title = {Safety and Feasibility of Irreversible Electroporation (IRE) in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective Study},
  journal = {Digestive Surgery},
  year = {2015},
  volume = {32},
  number = {2},
  pages = {90--97},
  doi = {10.1159/000375323}
}
Kostenlos starten →